Literature DB >> 5769885

Rubella vaccine trial in children.

I B Hillary, P N Meenan, A H Griffith, C C Draper, G D Laurence.   

Abstract

A study with RA 27/3 attenuated rubella virus vaccine (Plotkin strain) showed that this produced a significant antibody response in all of twenty-one vaccinated non-immune children without any appreciable marked clinical reactions. Serological examination of 53 non-immune and 29 immune siblings living in the same households failed to show any evidence of transmission of infection.

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5769885      PMCID： PMC1983468          DOI： 10.1136/bmj.2.5656.531

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  9 in total

1.  Intranasally administered rubella vaccine.

Authors:  S A Plotkin; T H Ingalls; J D Farquhar; M Katz
Journal:  Lancet       Date:  1968-11-02       Impact factor: 79.321

2.  Live attenuated rubella virus vaccines prepared in duck embryo cell culture. I. Development and clinical testing.

Authors:  E B Buynak; M R Hilleman; R E Weibel; J Stokes
Journal:  JAMA       Date:  1968-04-15       Impact factor: 56.272

3.  Attenuation of rubella virus by serial passage in primary rabbit kidney cell cultures. II. Experiments in animals.

Authors:  C Huygelen; J Peetermans
Journal:  Arch Gesamte Virusforsch       Date:  1967

4.  Clinical trials with a live attenuated rubella virus vaccine; Cendehill 51 strain.

Authors:  R M Du Pan; C Huggelen; J Peetermans; A Prinzie
Journal:  Am J Dis Child       Date:  1968-06

5.  Attenuated rubella virus. II. Production of an experimental live-virus vaccine and clinical trial.

Authors:  H M Meyer; P D Parkman; T C Panos
Journal:  N Engl J Med       Date:  1966-09-15       Impact factor: 91.245

6.  Haemagglutination-inhibition tests for rubella.

Authors:  C C Draper; A Kelly
Journal:  Br Med J       Date:  1969-01-18

7.  A new attenuated rubella virus grown in human fibroblasts: evidence for reduced nasopharyngeal excretion.

Authors:  S A Plotkin; J Farquhar; M Katz; T H Ingalls
Journal:  Am J Epidemiol       Date:  1967-09       Impact factor: 4.897

8.  Rubella-virus hemagglutination-inhibition test.

Authors:  G L Stewart; P D Parkman; H E Hopps; R D Douglas; J P Hamilton; H M Meyer
Journal:  N Engl J Med       Date:  1967-03-09       Impact factor: 91.245

9.  Clinical and laboratory studies with rubella vaccines in adults.

Authors:  J A Dudgeon; W C Marshall; C S Peckham; G T Hawkins
Journal:  Br Med J       Date:  1969-02-01
  9 in total
  7 in total

1.  Persistence of antibody induced by rubella vaccine (Wistar RA 27/3 strain) after six years.

Authors:  I B Hillary; D S Freestone
Journal:  J Hyg (Lond)       Date:  1975-12

2.  Rubella vaccination.

Authors: 
Journal:  Br Med J       Date:  1972-08-05

3.  Vaccination against rubella.

Authors: 
Journal:  Br Med J       Date:  1970-02-07

4.  Persistence of antibody after subcutaneous vaccination with Wistar RA27/3 rubella vaccine.

Authors:  I B Hillary
Journal:  J Hyg (Lond)       Date:  1971-09

5.  Trials of intranasally administered rubella vaccine.

Authors:  I B Hillary
Journal:  J Hyg (Lond)       Date:  1971-12

6.  Maternal rubella after the first trimester.

Authors: 
Journal:  Br Med J       Date:  1969-10-18

7.  Persistence of antibody 10 years after vaccination with Wistar RA27/3 strain live attenuated rubella vaccine.

Authors:  I B Hillary; A H Griffith
Journal:  Br Med J       Date:  1980-06-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.